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ABSTRACT
Diagnosis of a child with fragile X syndrome (FXS) is associated with parental
anxiety. Existing literature recommends FXS resources, but there has not been a formal
assessment of when parents learn about these resources, or their satisfaction with them.
Studies have demonstrated negative feelings surrounding the diagnostic experience of
FXS. This exploratory analysis assessed the gap in knowledge on parental satisfaction of
the recommended resources from healthcare providers during the time of diagnosis. We
predicted parents would not be satisfied with the way resources were presented to them.
We discussed parental satisfaction or dissatisfaction, utility of the recommended
resources, and determined what resources parents independently identified as valuable for
healthcare professionals and genetic counselors to recommend to families in the future.
Seven participants took an online questionnaire containing inclusion criteria and
demographic type questions. Four of these participants partook in further focus group
discussion (n = 3) or individual interview (n = 1) and discussed FXS resource satisfaction
and preferences. The results were analyzed descriptively.
Overall, participants were not satisfied with the information and advice they
received from providers at diagnosis. All participants expressed a need for more positive
and balanced information about FXS. Parents primarily relied on information and support
from national organizations like NFXF and FRAXA, Facebook groups, and national FXS
conferences. Two participants were not given any informational or support resources at
the time of diagnosis. Participants recommended that professionals educate families
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about specific resources at the time of diagnosis and provide actionable steps forward in
an age-appropriate manner.
This study suggests parents would like the names of specific resources at
diagnosis like national organizations, Facebook group names, local resources, and a way
to connect with a parent who has already experienced a FXS diagnosis. Parents feel
isolation and anxiety during a new diagnosis of their child, so it is important to emphasize
positivity and that a group of providers, therapists, and the entire FXS community is there
to support the family. Genetic counselors and providers should give age-appropriate
recommendations so parents can continue to adjust and adapt to their child’s FXS
diagnosis.
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CHAPTER 1: BACKGROUND
1.1 Fragile X Syndrome Genetics
Fragile X syndrome (FXS) is a genetic condition characterized by intellectual
disability, developmental delay, and behavioral issues. FXS is one of the most common
forms of inherited intellectual disability and is estimated to affect approximately 1 in
4,000 males and 1 in 8,000 females (Hunter et al., 2019; Van Remmerden et al., 2020).
The Fragile X Mental Retardation 1 (FMR1) gene, located at chromosome Xq27.3,
encodes a protein known as Fragile X Mental Retardation Protein, FMRP. FXS is caused
when the FMR1 gene is not functioning within nerve cells properly (Hunter et al., 2019).
A lack of this protein can lead to the behavioral and cognitive features seen in individuals
with FXS.
Fragile X syndrome is a trinucleotide repeat expansion disorder. The FMR1 gene
has a 5’ untranslated region containing a trinucleotide repeat sequence (Garber et al.,
2008). This region is made up of a cytosine-guanine-guanine (CGG) nucleotide triplet
that repeats a variable amount in all individuals. The typical number of CGG repeats in
FMR1 is 6 to 44 repeats, which is referred to as a normal allele (Finucane et al., 2012).
Males typically have one normal allele and women have two normal alleles. A normal
allele is unmethylated, so the gene is able to be transcribed and translated to make FMRP
(Hunter et al., 2019). The repeating region is unstable, and an expansion in the repetitive
sequence is possible, which can lead to premutation or full mutation of the gene
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(Sherman et al., 2005). If the CGG repeats expand past a certain threshold, it can become
hypermethylated, effectively turning the gene off by halting transcription of FMR1
(Hunter et al., 2019).
Individuals with 45 to 54 CGG repeats have an intermediate genotype, have a
small risk for expansion, and may have mild symptoms (Finucane et al., 2012). Some
mutations in this intermediate range are stable, while others are not and are at greater risk
of expanding to a premutation (Nolin et al., 1996). Someone with 55 to 200 CGG repeats
is known to have a FMR1 premutation and there is a risk for expansion in subsequent
generations to a full mutation due to the FMR1 instability (Nolin et al., 1996; Sherman et
al., 2005). The premutation allele is associated with the risk of developing a FMR1related disorder but does not cause classic FXS. An individual with more than 200
repeats has a full mutation, so methylation of FMR1 occurs, so no FMRP is made and
that individual has FXS (Garber et al., 2008; Hunter et al., 2019). Approximately 99% of
individuals with FXS have the expanded CGG repeat size, but 1% of individuals have
either a deletion or a point mutation in the FMR1 gene (McConkie-Rosell et al., 2005).
As mentioned earlier, the normal allele (less than 44 repeats) is generally
considered stable, so it is unlikely to expand as it gets transmitted to the next generation
(Monaghan et al., 2013). As the repeat size increases into the intermediate zone or to the
premutation allele, there is a greater chance of an expansion to occur (Hunter et al.,
2019). Expansion risk depends on CGG repeat size, maternal or paternal transmission,
and if there are AGG triplets interrupting the sequence (Eichler et al., 1996; McConkieRosell et al., 2005). In the general population, around 95% of individuals have one or two
AGG interruptions that stabilizes the FMR1 gene during transmission, which prevents
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DNA polymerase slippage during DNA replication, thereby preventing expansion. Some
individuals with the premutation can still have one or more AGG interruptions, which
greatly increases the stability (Villate et al., 2020). In the presence of an interrupting
AGG repeat, premutation carriers have a decreased risk of expansion of CGG repeats to
the full FMR1 mutation (Nolin et al., 2015).
Fragile X syndrome and FMR1-related disorders are inherited in an X-linked
manner (Sherman et al., 2005). Every person has 23 pairs of chromosomes, 22 pairs are
autosomes and are the same between males and females, and there is one pair of sex
chromosomes (typically XX or XY). FMR1 resides on the X chromosome, so males have
one copy of FMR1 since their sex chromosomes are “XY” and females have two copies
of the gene because their sex chromosomes are “XX” (Hunter et al., 2019). A mother
always passes one of her two X chromosomes to her child, while a father will pass on his
Y chromosome to his sons, and his X chromosome to his daughters. If a female is a
premutation carrier, she has a 50% chance of passing on the premutation, which resides
on one of her X chromosomes, to each of her children. When a female premutation
carrier transmits the premutation allele to the next generation, there is almost always an
expansion (Nolin et al., 2003). A male with the premutation will pass this allele to all of
his daughters, but none of his sons. The premutation in males can undergo a small
expansion, a contraction, or remain stable. The premutation very rarely expands to a full
mutation due to male transmission (Nolin et al., 2003).
1.2 Fragile X Syndrome Features and Management
There is a variable clinical phenotype observed in FXS. Individuals can range
from having learning difficulties but a normal IQ, to severe intellectual disability and/or
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autism (Garber et al., 2008). FXS is one of the most common forms of inherited
intellectual disability and is the most common inherited form of autism spectrum disorder
(Hunter et al., 2019; Van Remmerden et al., 2020). Each individual with FXS is unique,
but there are characteristic features of this condition. These features may affect males and
females, but males are typically more severely affected (Finucane et al., 2012).
Individuals can have physical features such as hypotonia, large ears, long face,
macroorchidism (in males), hypermobility of the joints, increased susceptibility to
seizures, mitral valve prolapse, and increased frequency of ear infections (Garber et al.,
2008). Common cognitive and behavioral features include various learning or intellectual
disabilities, autism spectrum disorder (ASD), motor or speech delays, behavior issues
(e.g. attention deficit hyperactivity disorder), shyness or difficulty with transitions,
echolalia, coprolalia, and/or stereotypies (Hunter et al., 2019; McConkie-Rosell et al.,
2005).
Females with a full mutation allele may have similar features as an affected male;
however, it is more likely that a female will have a more mild and subtle presentation
(McConkie-Rosell et al., 2005). Less than 50% of females with a full mutation allele
have intellectual disability (Spector et al., 2021). Females may have a normal IQ or only
slight learning disabilities, and they are also more likely to have minor physical
characteristics and psychological concerns in comparison to males with FXS (McConkieRosell et al., 2005). The most common manifestations are behavioral, such as: avoidant
personality, mood disorders, and stereotypic disorders (Spector et al., 2021). Non-random
X inactivation is thought to explain the wide spectrum of features in females and can
explain the milder phenotype seen in some females with the full mutation (Spector et al.,
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2021). Typically, the somatic cells in females undergo random X chromosome
inactivation where one X chromosome is transcriptionally silenced in each cell (Hall et
al., 2016). This results in roughly a 50/50 split of which X chromosome is active within
regions of the body. Variation in the activation ratio away from a typical 50/50 ratio can
cause the affected FMR1 premutation or full mutation allele to be disproportionately
active or inactive within the body, contributing to heterogeneity of FXS and FMR1–
related disorder features and severity (Hall et al., 2016).
FMR1-related disorders are associated with having a premutation allele and
include Fragile X Primary Ovarian Insufficiency (FXPOI) and Fragile X-Associated
Tremors/Ataxia syndrome (FXTAS) (Monaghan et al., 2013). FXPOI causes ovarian
dysfunction, and symptoms include early onset menopause, irregular menses, and
infertility. About 20% of women with a premutation can have features of FXPOI
(Finucane et al., 2012; Spector et al., 2021). More rarely, premutation carriers can
develop FXTAS. FXTAS more commonly affects males starting in their 50s and is
associated with tremors and progressive nerve degeneration, leading to balance and
coordination difficulty, and occasionally slurred speech (Finucane et al., 2012). Cognitive
decline is also a feature of FXTAS and can include memory loss, dementia, and a loss of
decision-making and executive functioning skills (Finucane et al., 2012).
There is currently no cure or standard treatment for Fragile X syndrome. The
management of FXS is based on treating an individual’s symptoms that present and
following the recommended surveillance guidelines (Hunter et al., 2019). Various
therapies are valuable to help an individual achieve their highest neurodevelopmental
potential. These include applied behavior analysis therapy (ABA therapy), speech
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therapy, occupational therapy, and early intervention (Garber et al., 2008). Seizures,
psychological, and behavioral features can be treated via medication(s). It is optimal for a
patient to receive a referral and have their care managed through a Fragile X clinic that is
part of the Fragile X Clinical and Research Consortium (FXCRC) (National Fragile X
Foundation). These clinics provide multidisciplinary care and can provide medications,
genetic counseling, consultations with appropriate specialists, referrals to other providers,
and help coordinate various therapies (Finucane et al., 2012). Many clinics partake in
research efforts and can help patients get involved in ongoing FXS research and clinical
trials.
1.3 Genetic Testing of Fragile X Syndrome
Due to varied clinical phenotypes, a FXS diagnosis is made based on genetic
testing of the FMR1 gene to assess the number of CGG repeats (Garber et al., 2008). The
American College of Medical Genetics (ACMG) Standards and Guidelines for Fragile X
testing recommends genetic testing for:
Fragile X syndrome:
1. Individuals of either sex with intellectual disability, developmental delay,
or autism, especially if they have (a) any physical or behavioral characteristics
of fragile X syndrome, (b) a family history of fragile X syndrome, or (c) male
or female relatives with undiagnosed mental retardation.
2. Individuals seeking reproductive counseling who have (a) a family history
of fragile X syndrome or (b) a family history of undiagnosed mental
retardation.
3. Fetuses of known carrier mothers.
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4. Affected individuals or their relatives in the context of a positive
cytogenetic fragile X test result who are seeking further counseling related to
the risk of carrier status among themselves or their relatives. The cytogenetic
test was used prior to the identification of the FMR1 gene and is significantly
less accurate than the current DNA test. DNA testing on such individuals is
warranted to accurately identify premutation carriers and to distinguish
premutation from full mutation carrier women.
Ovarian Dysfunction:
1. Women who are experiencing reproductive or fertility problems associated
with elevated follicle stimulating hormone (FSH) levels, especially if they
have (a) a family history of premature ovarian failure, (b) a family history of
fragile X syndrome, or (c) male or female relatives with undiagnosed mental
retardation.
Tremor/Ataxias:
1. Men and women who are experiencing late onset intention tremor and
cerebellar ataxia of unknown origin, especially if they have (a) a family
history of movement disorders, (b) a family history of fragile X syndrome, or
(c) male or female relatives with undiagnosed mental retardation. (Sherman et
al., 2005, p. 586)
Trinucleotide repeat size and methylation status needs to be determined on the
FMR1 gene through polymerase chain reaction (PCR) and Southern blot analysis
(Spector et al., 2021). PCR is able to amplify the repeated region on FMR1 to allow the
number of repeats to be determined. PCR decreases in effectiveness as the number of
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repeats increases and it is able to better determine repeat size up to a premutation allele.
Southern blot analysis can determine methylation status as well as approximate allele
size. ACMG recommends that laboratories combine the usage of traditional PCR with
Southern blot analysis (Monaghan et al., 2013). If repeat-primed PCR or methylation
PCR is used, this can decrease the use of Southern blot analysis. Laboratories can use
various tests depending on presenting clinical features (Monaghan et al., 2013).
Monaghan et al. (2013) explains that, since full mutations of over 200 CCG repeats
account for over 99% of FXS cases, the tests are over 99% sensitive and 100% specific.
If testing identifies a full FMR1 mutation allele in a male, this is considered diagnostic
because FXS is 100% penetrant. In females, these results can be diagnostic if her clinical
features are consistent with FXS, but it should be noted that less than 50% of females
with a full mutation allele will be affected with intellectual disability (Spector et al.,
2021). Less than 1% of FXS cases are caused due to a FMR1 sequence variant or a partial
or full gene deletion (Sitzmann et al., 2018). These patients would usually be detected
with a multi-gene sequencing panel or deletion/duplication analysis that includes FMR1
(Hunter et al., 2019).
1.4 Fragile X Syndrome Results Counseling and Resources
It is known that patients primarily rely on their healthcare professionals to provide
them with credible information about their condition (Genetic Alliance, 2010). Genetic
counselors are valuable and serve as a resource about genetic conditions for patients, as
well as other healthcare professionals (Genetic Alliance, 2010). Education that usually
occurs during a results disclosure of FXS includes the inheritance pattern, the genetics of
the condition, risk assessment for other family members, potential prognosis,
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management options, and patient resources (McConkie-Rosell et al., 2005). In a FXS
results disclosure session, the parent or guardian can be overwhelmed emotionally due to
their child’s diagnosis and the large amount of information provided during the disclosure
session(s). Parents may feel in shock at the time of diagnosis, feel uncertainty about their
child’s long-term development, and are often coping with many new feelings and fears
(Lebmann and Sarimski, 2013). Genetic counselors can help support the family by
gathering relevant local, national, and online support groups and resources (Goodwin et
al., 2015).
A study looking at the diagnostic experience of parents of children affected with
22q11.2 deletion syndrome, Fragile X syndrome, and Down syndrome found that the
diagnostic experience is generally negative because healthcare providers show a lack of
support and provide unsatisfactory quantity and quality of information on the condition
(Goodwin et al., 2015). A parent experiences a new diagnosis more positively when
information is presented in a calm and supportive manner (Goodwin et al., 2015). Parents
expect the healthcare professional to understand their emotional distress at the time of
diagnosis and deliver advice and provide information about support, treatment, and next
steps (Lebmann & Sarimski, 2013). Lebmann and Sarimski (2013) studied parental
experiences of FXS diagnosis and found that some parents overall felt grateful for
understanding the reason for their children’s delays, but 58.4% stated they desired more
information about the disability, and 52.8% wanted more emotional support from the
professional during the diagnosis. Support groups and parents’ groups are known to
benefit parents and help them cope with a child’s diagnosis (Finnegan et al., 2014). One
study found that 81.3% of parents found support groups to be important following a FXS
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diagnosis (Lebmann & Sarimski, 2013). Parents may cope and manage their reactions to
a child’s diagnosis through information seeking behavior about the condition as a way to
“restore order in a chaotic existence” (Starke & Moller, 2002). When parents have a child
with a disability, it is common that a mother will seek out advice from the healthcare
provider to help her understand her child’s needs, while a father is more likely to manage
using resources such as medical literature or books (Starke & Moller, 2002).
It is important that the healthcare professional is well informed about the best
resources available. Resources can include printed information pamphlets, websites,
information about patient advocacy groups, books, or even national organizations
(Genetic Alliance, 2010; Uhlmann et al., 2010). Patients have reported a preference for
written materials such as brochures, pamphlets, and books over websites (Genetic
Alliance, 2010). Mac et al. (2020) states that online resources are often written above the
recommended reading level and can be perceived as more difficult to understand than
printed materials, which highlights the importance of finding patient-friendly resources.
Recently, social media is allowing patients and their families to be more involved in their
care and advocacy. Such platforms are becoming a medium to empower patients, increase
a sense of community and participation, and increase research recruitment (Pogue et al.,
2018). The complexity of the many resources makes it important that providers are
comfortable with the resources that they recommend to patients. Uhlmann et al. (2010)
warns that not all advocacy and support groups benefit each family in the same way, so
healthcare providers must assess every family individually to determine which group(s)
to introduce a family to.
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There are many Fragile X syndrome resources that exist, but families often do not
know of these resources without appropriate guidance. McConkie-Rosell et al. (2005)
recommended resources such as National Fragile X Foundation, FRAXA Research
Foundation, family-oriented books and articles, and other online resources. The National
Fragile X Foundation provides informational resources about FXS and FMR1-related
disorders. They also maintain support groups and a Facebook page for affected families
(Finucane et al., 2012). The National Fragile X Foundation provides additional
information about current research studies, the Fragile X Online Registry with Accessible
Research Database (FORWARD) natural history study, and the location of Fragile X
Clinics. The FRAXA Research Foundation is also a good resource dedicated to FXS
research. FRAXA also has information surrounding medical treatment and education
strategies to use for children with FXS and contains a for-parents-by-parents guide
relating to challenges of daily life with FXS. In addition to websites, there is a parentwritten physician-reviewed book called “Children with Fragile X Syndrome: A Parent’s
Guide” by Jayne Dixon Weber including information about FXS concerns, daily and
family life, child development and education, as well as family advocacy. Resources like
the ones listed, along with a strong healthcare/social team and personal coping strategies
help families make a successful adjustment to a new diagnosis (Lebmann & Sarimski,
2013).
1.5 Rationale of Study
There has been little research conducted to assess the feelings and satisfaction of
current resources that exist for FXS. There is no literature to our knowledge that assesses
how parents of children with FXS feel about the resources they are provided when their

11

child is newly diagnosed with the condition. Existing literature recommends resources,
but there has not been an assessment of when parents learn about these resources or their
satisfaction with the resources that healthcare professionals provide (i.e. Finucane et al.,
2012; McConkie-Rosell et al., 2005). Goodwin et al. (2012) reported a negative outlook
and feelings of lack of support surrounding the diagnostic experience for various
conditions: 22q11.2, Down syndrome, and related conditions, including Fragile X
syndrome. Lebmann and Sarimski (2013) also found negative feelings surrounding the
diagnostic experience of FXS. This demonstrates that parents need support when their
child is diagnosed with a chronic condition, so it is important that the best resources are
being provided to families.
Genetic counselors often play a direct and important role in disclosing a new
genetic diagnosis and providing the appropriate resources to families with a genetic
condition. A genetic counseling session is often recommended to increase understanding
about the condition, management, and resources, with the goal of reducing family stress
and anxiety (Genetic Alliance, 2010). Genetic counselors are not the only healthcare
providers to explain a diagnosis of FXS, and not all providers can dedicate the same
amount of time to a result disclosure.
1.6 Purpose of Study
The purpose of this study was to assess parental satisfaction with the
recommended resources they received at the time of a FXS diagnosis of their child.
Parents with children who were diagnosed with a full FMR1 mutation in the past 10 years
were targeted to take an initial survey to meet study criteria. A focus group and one-onone interviews were used to gather information about parental satisfaction with current
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FXS resources and their satisfaction with the resources healthcare professionals are
recommending at the time of diagnosis. The study identified common resources that are
provided to parents as they receive a FXS diagnosis. We hypothesized that parents would
not be fully satisfied with the way resources were presented to them at the time of
diagnosis. This study aimed to improve the diagnostic experience for families receiving a
FXS diagnosis by identifying the resources that parents find most informative, resources
they dislike for any reason, and those they wish they could have learned about sooner.
Providing helpful resources improves the support a family feels from their health
provider, thereby promoting a more positive diagnostic experience. This information will
benefit the genetic counseling profession and other healthcare providers by identifying
the resources that parents find most informative and helpful to improve the FXS
diagnostic experience, as well as patient-provider relationships. Ultimately, this study
was an exploration of how parents view resources at diagnosis. It can be used as a point
of reference for genetic counselors and other healthcare professionals to begin developing
a more comprehensive list of resources to introduce parents to at the time their child is
diagnosed with FXS.
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CHAPTER 2
ASSESSING PARENTAL SATISFACTION OF CURRENT FRAGILE X SYNDROME
RESOURCES PROVIDED AT DIAGNOSIS1

______________________
1Michalski,

M., Ferrante, R., McConkie-Rosell, A., & Drazba, K. To be submitted to
Journal of Neurodevelopmental Disorders.
14

2.1 Abstract
Diagnosis of a child with fragile X syndrome (FXS) is associated with parental
anxiety. Existing literature recommends FXS resources, but there has not been a formal
assessment of when parents learn about these resources, or their satisfaction with them.
Studies have demonstrated negative feelings surrounding the diagnostic experience of
FXS. This exploratory analysis assessed the gap in knowledge on parental satisfaction of
the recommended resources from healthcare providers during the time of diagnosis. We
predicted parents would not be satisfied with the way resources were presented to them.
We discussed parental satisfaction or dissatisfaction, utility of the recommended
resources, and determined what resources parents independently identified as valuable for
healthcare professionals and genetic counselors to recommend to families in the future.
Seven participants took an online questionnaire containing inclusion criteria and
demographic type questions. Four of these participants partook in further focus group
discussion (n = 3) or individual interview (n = 1) and discussed FXS resource satisfaction
and preferences. The results were analyzed descriptively.
Overall, participants were not satisfied with the information and advice they
received from providers at diagnosis. All participants expressed a need for more positive
and balanced information about FXS. Parents primarily relied on information and support
from national organizations like NFXF and FRAXA, Facebook groups, and national FXS
conferences. Two participants were not given any informational or support resources at
the time of diagnosis. Participants recommended that professionals educate families
about specific resources at the time of diagnosis and provide actionable steps forward in
an age-appropriate manner.
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This study suggests parents would like the names of specific resources at
diagnosis like national organizations, Facebook group names, local resources, and a way
to connect with a parent who has already experienced a FXS diagnosis. Parents feel
isolation and anxiety during a new diagnosis of their child, so it is important to emphasize
positivity and that a group of providers, therapists, and the entire FXS community is there
to support the family. Genetic counselors and providers should give age-appropriate
recommendations so parents can continue to adjust and adapt to their child’s FXS
diagnosis.
2.2 Introduction
Fragile X syndrome (FXS) is an X-linked genetic condition characterized by
intellectual disability, developmental delay, behavioral issues, and certain physical
features. FXS is one of the most common forms of inherited intellectual disability caused
by a trinucleotide repeat expansion in the promoter region of the Fragile X Mental
Retardation 1 (FMR1) gene located at Xq27.3 (Hunter et al., 2019). Normally, FMR1
contains a cytosine-guanine-guanine (CGG) triplet that repeats 6 to 44 times. The normal
allele is stable, unmethylated, and does not cause FXS or FMR1-related disorders
(Finucane et al., 2012; Hunter et al., 2019; Monaghan et al., 2013). Occasionally, due to
polymerase slippage during DNA replication, the expansion may increase during
transmission to the next generation into the intermediate or grey zone (45-54 repeats),
premutation (55-200 repeats), or eventually into the full mutation (200+ repeats) (Nolin
et al., 1996). The intermediate genotype has a risk for expansion to the premutation, but
not the full mutation (Nolin et al., 1996). The premutation allele can expand to the full
mutation in subsequent generations and is associated with an increased risk of developing
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FMR1-related disorders such as Fragile X Primary Ovarian Insufficiency (FXPOI) and
Fragile X-Associated Tremor/Ataxia syndrome (FXTAS) (Monaghan et al., 2013). A
female premutation carrier almost always transmits an expansion to the next generation,
whereas males rarely experience expansion at transmission (Nolin et al., 2003). The
FMR1 gene becomes methylated at the full mutation causing FXS (Hunter et al., 2019).
FXS has a variable clinical phenotype and individuals can range from having
learning difficulties to severe intellectual disability and/or autism (Garber et al., 2008).
Typically, males experience more severe features while females are more likely to have
minor physical characteristics and more mild psychological concerns (Finucane et al.,
2012; McConkie-Rosell et al., 2005). Less than 50% of females with a full mutation
allele have intellectual disability (Spector et al., 2021). Common physical features
include hypotonia, large ears, long face, macroorchidism (in males), hypermobility of
joints, as well as cognitive and behavioral features like intellectual disabilities, autism
spectrum disorder (ASD), and motor or speech delays (Garber et al., 2008; Hunter et al.,
2019; McConkie-Rosell et al., 2005). Ideally, after diagnosis, a patient is referred to a
Fragile X clinic that is part of the Fragile X Clinical and Research Consortium (FXCRC)
to ensure appropriate multidisciplinary care (Finucane et al., 2012).
Patients primarily rely on healthcare professionals to provide them with credible
information about their condition (Genetic Alliance, 2010). Genetic counselors serve as
resources about genetic conditions for patients as well as other healthcare professionals
(Genetic Alliance, 2010). Education that usually occurs during a results disclosure of
FXS includes inheritance pattern, the genetics of the condition, risk assessment for other
family members, potential prognosis, management options, and patient resources
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(McConkie-Rosell et al., 2005). In a result disclosure of FXS, the parent can be
emotionally overwhelmed due to their child’s diagnosis and the large amount of
information introduced and reviewed (Lebmann & Sarimski, 2013). Parents expect the
healthcare professional to understand their emotional distress at the time of diagnosis and
deliver advice and information about support, treatment, and next steps (Lebmann &
Sarimski, 2013). Genetic counselors can help support the family by gathering relevant
local, national, and online support groups and resources (Goodwin et al., 2015).
A study found that parents of children affected with 22q11.2 deletion syndrome,
FXS, and Down syndrome generally report having a negative experience when receiving
the diagnosis because healthcare providers show a lack of support and provide
unsatisfactory quantity and quality of information on the condition (Goodwin et al.,
2015). A parent experiences a diagnosis more positively when information is presented in
a calm and supportive manner (Goodwin et al., 2015). Lebmann and Sarimski (2013)
found that 58.4% of parents stated they desired more information about the disability, and
52.8% wanted more emotional support from the professional during the diagnosis of
Fragile X Syndrome. These researchers also found that 81.3% of parents consider support
groups to be important following a FXS diagnosis. Parents may cope and manage their
reactions to a child’s diagnosis through information seeking behavior about the condition
as a way to “restore order in a chaotic existence” (Starke & Moller, 2002). When parents
have a child with a disability, it is common that a mother will seek out advice from the
healthcare provider to help her understand her child’s needs, while a father is more likely
to manage using resources such as medical literature or books (Starke & Moller, 2002).
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It is important that the healthcare professional is well informed on the best
resources available. Resources can be printed information pamphlets, electronic websites,
information about patient advocacy groups, books, or even national organizations
(Genetic Alliance, 2010; Uhlmann et al., 2010). Patients generally prefer written
materials such as brochures, pamphlets, and books over websites (Genetic Alliance,
2010). Mac et al. (2020) stated that online resources are often written above the
recommended reading level and can be perceived as more difficult to understand than
printed materials. However, recently, social media has become a medium to empower
patients, increase a sense of community and participation, and increase research
recruitment (Pogue et al., 2018). The complexity of the many resources makes it
important that providers are comfortable with the resources they recommend to patients.
Uhlmann et al. (2010) warns that not all advocacy and support groups benefit each family
in the same way, so healthcare providers must assess every family individually to
determine which group(s) to introduce a family to.
McConkie-Rosell et al. (2005) recommended resources such as National Fragile
X Foundation, FRAXA Research Foundation, family-oriented books and articles, and
other online resources. The National Fragile X Foundation provides informational
resources, current research studies, and locations of Fragile X clinics. They also maintain
support groups and Facebook pages (Finucane et al., 2012). FRAXA Research
Foundation is dedicated to FXS research and informing about medical treatment and
education strategies for children with FXS. Additionally, the book “Children with Fragile
X Syndrome: A Parent’s Guide” by Jayne Dixon Weber can be useful for families. A
combination of resources, a strong healthcare/social team, and personal coping strategies
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help make a successful adjustment to a new diagnosis in the family (Lebmann &
Sarimski, 2013).
There has been little research conducted to assess the feelings and satisfaction
parents have of resources that exist for FXS. There is no literature to our knowledge that
assesses how parents of children with FXS feel about the resources they are provided
when their child is newly diagnosed with the condition. Existing literature (i.e. Finucane
et al., 2012; McConkie-Rossel et al., 2005) recommends resources but there has not been
an assessment of when parents learn about these resources or their satisfaction with the
resources that healthcare professionals provide. Lebmann and Sarimski (2013) found
historically negative feelings surrounding the diagnostic experience of FXS. It is
important that parents find support when their child is diagnosed with a chronic
condition, so providing good resources is beneficial to everyone involved. While genetic
counselors are not the only professionals involved in a results disclosure, they do play a
role in disclosing a new diagnosis and discussing the condition, management, and
resources, with the goal of reducing family stress and anxiety (Genetic Alliance, 2010).
The purpose of this exploratory analysis was to assess parental satisfaction with
the recommended resources they received at the time of a FXS diagnosis of their child.
Providing helpful resources improves the support a family feels from their provider,
thereby promoting a more positive diagnostic experience. This information will benefit
the genetic counseling profession and other providers by identifying the resources that
parents find most informative and helpful to improve the Fragile X diagnostic experience
as well as patient-provider relationships.
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We predicted that parents would not be fully satisfied with the way resources
were presented to them at the time of diagnosis. The parents provided recommendations
for the kind of information that is most beneficial to them and explained why certain
information is more valued at the time of diagnosis. This study aimed to assess the types
of resources healthcare professionals recommend parents review when their child is
diagnosed with FXS. The researchers then discussed with parents their satisfaction or
dissatisfaction and the utility of the recommended resources. Another goal of this study
was to learn which resources parents discovered individually to fill gaps in desired
knowledge about FXS. Ultimately, this exploratory analysis studied how parents are
exposed to resources at diagnosis. This study can be used as a point of reference for
genetic counselors and other healthcare professionals to begin developing a more
comprehensive list of resources to introduce parents to at the time their child is diagnosed
with FXS.
2.3 Materials and Methods
2.3.1 Participants and Recruitment
This study was approved by the Institutional Review Board at the University of
South Carolina in July 2021 (Pro00113410). Participants were over the age of 18 years
old and were parents or caretakers of children under the age of 18 years old with a full
Fragile X mutation, diagnosed within the past 10 years. Only English-speaking
participants were included in this study due to insufficient resources for translation and
interpretation. Survey exclusion criteria is detailed in Figure 2.1.
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Figure 2.1 Methods by which participant eligibility was stratified. Participants included
in the white boxes were excluded from the study due to unmet inclusion criteria and their
responses were not incorporated into data analysis.
Of the seven participants who were identified to qualify for a focus group, one did
not provide contact information and one respondent was unable to be contacted by email
or phone. Both of their survey responses were included in the quantitative portion of data
analysis. One participant was identified to not meet full criteria during the focus group, as
the diagnosis of FXS was made in adulthood, so her responses were not included in
qualitative or quantitative analysis. Ultimately, three qualified participants were
scheduled for a focus group discussion and one participant was interviewed individually.
Recruitment for this study was done at both a national level through the National
Fragile X Foundation (NFXF) and a local level through the Greenwood Genetic Center
(GGC). Both organizations were involved in social media postings alerting their
followers about the study (Appendices A and B). The social media posts included a brief
description of the study as well as a link to a pre-focus group survey for GGC or to the
research portal and pre-focus group survey for NFXF. NFXF posted on their research
portal about the study as well as emailed an advertisement for the study in a research
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round up to parents of children with FXS (Appendix C). GGC additionally posted
advertisement flyers in their offices (Appendix D). Participation was voluntary, and those
who participated in the online survey had the option to opt in to a further focus group
discussion. The participants also had an opportunity to be entered into a raffle at the end
of the focus group and interview for a $25 Amazon gift card.
2.3.2 Materials and Measures
This exploratory analysis consisted of a self-applied online questionnaire and a
subsequent focus group or interview conducted by the primary researcher via a phone call
or video conference. Both the online questionnaire and the focus group discussion
questions were created by the primary researcher and reviewed by the research committee
for content, clarity, and accuracy. The focus group discussion questions were created
with the intent to answer study objectives. Demographic questions were developed by
researching other surveys and modeling the questions in a similar fashion. The online
questionnaire was developed through Qualtrics and incorporated skip logic to tailor the
questions to each participant to ensure they met study requirements. The questionnaire
contained items about inclusion criteria, when and where parents received their child’s
diagnosis, FMR1 mutation status, contact information, and demographics (Appendix E).
Answers were structured in multiple choice, select all that apply, and open-ended text
entry. Participants were contacted via telephone to obtain an email, or via email with a
Doodle Poll questionnaire to select multiple times that fit in their schedule to participate
in the focus group. If a participant was unable to participate in the scheduled focus group,
they were offered a phone interview option.
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The focus group was conducted over a video conference meeting protected by a
passcode. The individual interview was conducted via telephone. Both the focus group
and interview used the same set of questions and were conducted by the primary
researcher. See Appendix F for the focus group script and questions and Appendix G for
the interview script and questions. Participants were asked nine overarching questions,
with supplementary questions asked when appropriate to elicit further responses about
participant background, types of resources they were exposed to at the time of diagnosis,
satisfaction or dissatisfaction with these resources, the kind of information and resources
they looked for near their child’s diagnosis, and if there were gaps in the information
parents desired.
2.3.3 Procedures
From the initial recruitment flyer or research posting, participants were provided
the link to the survey or could directly click the link for the survey on the electronic post.
The first page of the survey outlined the specific details of the project and provided
information about the survey and subsequent focus group. Participants needed to consent
to proceed to the rest of the survey. Participants were able to leave the questionnaire at
any time and could skip any question. If a participant did not answer a question that
determined their eligibility, they were prompted to answer, but were still able to skip the
question. Completing the survey served as consent to be contacted about participating in
the focus group.
Due to an error in the survey logic, some participants were unable to complete the
full survey, but were still able to leave a telephone number after completing the eligibility
questions. In the instances where these participants met criteria, the researcher called
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these individuals to gauge their interest and requested a second completion of the survey,
then proceeded with the interview/focus group scheduling. This resulted in three partially
complete and duplicated responses which were eliminated from data analysis. The
researcher was unable to contact one qualified participant, so the incomplete response
was not included in the analysis.
The primary investigator contacted volunteers via email with a DoodlePoll
questionnaire to schedule the focus group. Those who could not schedule a focus group
participated in a one-on-one interview. A week before the focus group and interview,
participants were provided the discussion questions. At the beginning of the focus group
and interview, verbal consent was obtained to record the meeting. The phone interview
was recorded with Apple Simple Recorder and the Zoom meeting was recorded via
Zoom. Both were saved to the primary investigator’s password-protected laptop and were
transcribed verbatim. All identifying information was removed from transcriptions to
protect participant identity. Audio and video recordings were destroyed upon completion
of transcription. Participants were emailed after the interview or focus group with links to
resources that were discussed for their future reference as well as information about other
FXS resources that were compiled by the researcher (Appendix H). Data was collected
from July 2021 to December 2021. One participant was selected by lottery for the
Amazon gift card, and was emailed the redemption code.
2.3.4 Data Analysis
In order to meet the objectives of the study, the data collected required
quantitative and qualitative analysis. The pre-focus group survey was analyzed
quantitatively in Excel. Much of the data from this pre-focus group survey was
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categorical, so percentages and frequencies were calculated. Duplicated or partially
completed survey responses were discarded from final analysis. The focus group and
interview responses were jointly analyzed through a descriptive model for each
discussion question. Each transcript was analyzed and used to describe what participants
agreed on and where participants had contradictory viewpoints.
2.4 Results
2.4.1 Demographics
Of the initial responses to the survey, seven responses submitted by six eligible
individuals were analyzed. The sample population consisted of all mothers (n = 6, 100%)
who identified as females and as the primary caregiver of their child with FXS. The most
common racial and ethnic identity was Caucasian/White (n = 5, 83.33%) and one
participant (n = 1, 16.6%) identified as Hispanic/Latino. There were three participants
(50%) who had completed a Master’s or Doctoral degree, two participants (33.33%) with
a Bachelor’s degree, and one participant (16.67%) who had some college education. All
six participants (100%) had a son with FXS, and two participants (33.33%) also had a
daughter with a full fragile X mutation who was symptomatic. As mentioned earlier, one
participant took the survey twice because she has two affected children, a son and a
daughter, and during the focus group, one participant shared that she also has an affected
son and daughter.
2.4.2 Fragile X Syndrome Diagnosis
Every participant (n = 6, 100%) responded that they were present at the time their
child was diagnosed with FXS. Based on survey responses, the average age at diagnosis
was approximately 1.67 years, and participants learned the diagnosis of their child an
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average of 2.67 years ago. The age range of the affected children was between four
months old and seven years old, and the age at diagnosis ranged from the first few weeks
of life to about two and a half years old. The majority of participants (n = 4, 66.67%) had
never visited a specialized fragile X clinic, and two participants (33.33%) reported that
they had been seen at a fragile X clinic.
The details of the type of provider who gave the participants their child’s
diagnosis, as well as which healthcare professional discussed resources with the family, is
presented in Figure 2.2. The survey did not distinguish if the resources needed to be
discussed in any specific time frame, but asked which healthcare professionals had ever
discussed resources with the parents. All six participants had spoken with a healthcare
professional about FXS resources. No participant selected that a psychologist, special
educator, or educator provided them with a diagnosis or resources for their child. One
participant selected that they had received resources additionally from a board-certified
behavioral analyst (BCBA).
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Figure 2.2 Highlights which healthcare provider discussed resources with the participant,
provided a diagnosis, or discussed resources and provided a diagnosis.
2.4.3 Qualitative Analysis
For reference, Participant 3 was interviewed one-on-one, and Participant 2,
Participant 5, and Participant 6 were in a focus group discussion together. Participants 1
and 4 are not included in the following analysis as they completed the survey but did not
participate in an interview or focus group.
2.4.3.1 Introductions and discussion of how a diagnosis was received. The four
interviewed participants were the first in their family to learn about FXS and did not have
prior experience with FXS. There were two participants with two affected children, three
of the four saw a genetic counselor after diagnosis, and there was a range of ages at
diagnosis, as mentioned previously. Participant 3 had two affected children, an older son
who was diagnosed first, and younger daughter who also was symptomatic and has a full
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mutation. Participant 3 was the only participant to not see a genetic counselor after
diagnosis of her children.
Participant 2 had two affected children, a younger son and older daughter. Her
son was diagnosed first at eight months of age after failing to meet appropriate
milestones; he was referred to genetic counseling by an early intervention specialist.
Testing found a mosaic normal allele and full mutation allele in the son, and a geneticist
recommended FXS testing for the daughter who was about two and a half years old at the
time. Participant 2’s daughter was diagnosed with a full FXS mutation but was not
mosaic. Regarding her son’s diagnosis, she stated: “luckily, it was very early on, on so
we had the ability to have lots of resources.”
Participant 6 reported that she has an affected son who is four months old, who
was diagnosed at six weeks after postnatal testing following her diagnosis as a
premutation carrier during pregnancy. Due to concern for early onset ovarian
insufficiency following struggles with infertility, the participant was tested for FXS
during her pregnancy. She received prenatal genetic counseling about the 50% risk of
having an affected son. Her son was tested for FXS at birth, and the pediatrician who
disclosed the test results confirming the FXS diagnosis referred her to a genetics team for
more information.
•

“It was such a devastating appointment. My husband ended up in the hospital with
suicidal thoughts and um I had to go on antidepressants because of the things this
uh genetic counseling team told us about our child…It was very much like this
was something that I uh did wrong as a parent, and that I should of chose.
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Basically, told me I should have terminated my pregnancy once I found out I was
a carrier.” – Participant 6
Participant 5 found out her son had FXS when he was three weeks old from a state
newborn screening research initiative which offered screening for spinal muscular
atrophy and FXS in a research setting. The state contacted the family through a phone
call to disclose the positive result and then they followed up with a genetic counselor and
research team at a university.
2.4.3.2 Resources on FXS that healthcare professionals recommended
parents at diagnosis. Participants were recommended a few different methods of
learning more about FXS and how to care for their child. Two participants were not given
much information and told to do their own research online. Of those two individuals, one
mother was informed about medical assistance programs.
•

“We didn't get emails. We didn't get pamphlets; we didn’t get resources like we
got literally not it was like just go out and figure it out.” – Participant 6

•

“Okay basically they just said look into the local groups and look online on
Facebook and that was it.” – Participant 3
Participant 2 was given multiple handouts, pamphlets, and national organization

names and referred to a FXS clinic.
•

“A lot of like, business cards and pamphlets. It may be. I think at that point, the
fragile X Foundation had been like the beginner's guide to fragile X. Possibly was
like maybe 30-page handout kind of document that I was handed or maybe
emailed the PDF.” – Participant 2
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•

“There's a fragile X clinic in Cleveland that's less than an hour from me. So we
did, I would say meet with that position within probably six weeks to two
months.” – Participant 2

Participant 5 was told to only research through reputable sites like university pages and
national organizations. No participant had been given any books or support group
contacts at the time of their child’s diagnosis.
•

“We were told by the genetic counselor, to actually stay off Google and not
Google it and to only reference that specific website that I was talking about and
use those documents and use that website to learn more.” Participant 5

Participant 5 also stated that her son is being followed in a three-year long research
initiative, but did not disclose the university or the specific website she mentioned in the
above quote, but described it:
•

“…they had like different documents like PDFs where it is. They were very
specific as to here's a document if you want to talk to your child's pediatrician or
doctor about their diagnosis, and then there was another one that was specifically
like, here's how to tell your family members about your child and their diagnosis,
and like how it could also potentially affect them…” – Participant 5

Participant 6 met with a genetics team after diagnosis to learn more about FXS and future
implications. A genetic counselor discussed FXS with her.
•

“The only thing we actually, saw was this PowerPoint that was written like with a
medical angle and not being in a medical profession. Like it was basically just
like not, it was just not helpful” – Participant 6
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Participants were also asked to expand on their satisfaction or dissatisfaction and
thoughts on the resources they were recommended at diagnosis. Some responses were:
•

“Totally unsatisfied, ya I had to do a lot of research myself. It was by talking to
other people, and letting uh them know of my son’s diagnosis was, that I was
connected to other parents in the area who had kids with Fragile X” - Participant 3

•

“It wasn’t very personalized, it was just like take this and read it, take this and
read it” – Participant 2
2.4.3.3 Initial information parents most wanted to learn about after

diagnosis. Half of the participants in this study stated they wanted more information
about their child’s developmental potential and prognosis, and what they should do
moving forward from a diagnosis. Two participants also discussed the importance of
learning about medical implications, features of FXS, and their varied abilities, while
some were concerned about long term care and how they should prepare for the future.
•

“Like what to expect for the long haul, like was you know, are there kids who can
live on their own like [son’s name], specifically [son’s name], because boys are
more affected than girls. What is the trajectory in terms of his like potential and
like what resources can I get, and hit the ground running to have him reach you
know the potential that he's meant to reach.” – Participant 3

•

“Your son or child has this diagnosis. Here's what you should do. These are the
steps that you should take going forward.” – Participant 5

•

“I was hysterical and I just said, you know, should I be saving money for medical
funds? Because that's what it sounds like. Because right now we have a college
fund.” – Participant 6
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•

“What do I need to do for his future, especially at the point where I'm no longer
here, and my husband is no longer here to care for him. What happens to him,
then?” – Participant 5

•

“One thing I'm going to add but maybe a few of the medical things that show up
along the way.” – Participant 2

•

“I remember asking for like a template, like if it's truly is a spectrum, like what
are the phases of the spectrum” – Participant 6

•

“I want to know hey, if they have verbal communication, or if they have moderate
like, fine motor skills, like what are those different layers to what that spectrum
means.”– Participant 6
Participant 3 expressed that the information she wanted to learn, including long-

term prognosis, necessary therapies, and future concerns, were the same in regards to her
affected son and daughter.
2.4.3.4 Resources on FXS that parents found after their child’s diagnosis. The
participants found information on national organization webpages, like NFXF and
FRAXA, through internet-based searches. Two participants found information about
ongoing research on the NFXF website as well as through other organizations. All four
participants found active Facebook groups to join which allowed them to connect with
other parents online. Two participants also found more resources relating to therapies and
intervention services for their children.
•

“…getting information from the Fragile X Foundation about studies that are
available for your children. And for yourself, like, if obviously, you know, if your
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children have it, someone is a carrier. So having the resources for the carrier also,
like, I was able to educate myself through those web pages.” – Participant 3
•

“I found a lot of helpful information in the National fragile X website…” –
Participant 5

•

“I dig and connected with a social worker, who did help us get into the birth to
three program. But locally, there's there's no real community of fragile X parents
here in Wisconsin. There's a branch in Milwaukee through the National Fragile X
Foundation, but the woman who runs it, this is her first year, so the community is
she she's trying to build a community now … like to me, the only thing I've really
been able to use is the Facebook page.” – Participant 6

•

“The Facebook groups, the specialists, the clinics we have done a lot of research,
like I mentioned. Stanford has a girl band study that we’re a part of. Cincinnati
Children's, Dr. Erickson is one of the biggest, and so everything is under his care,
so we get in a lot of research with that.” – Participant 2

•

“…how to adapt ABA for fragile X kids that I was able to send to, like our
therapist … I Googled it and it came up. But also, I called the fragile X
Foundation” – Participant 3
Participant 3 expressed that being able to communicate with other parents taught

her what kinds of behaviors to expect and how to manage various behavioral differences
or challenges that her children may have.
•

“I found like just talking to people who've been where I am or people like in the
area… who are going through the same things and their kids are the same age as
mine …I think that like, we've just been a resource for each other.” – Participant 3
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One mother had mixed feelings about Facebook groups:
•

“The great thing about it is that obviously there’s a lot of parents and everyone’s
really loving and positive. The bad thing about is you see everything… like
because it’s a spectrum, you don’t know where your kid’s going to fall, and some
of it is really overwhelming.” – Participant 6

Participant 3 found specific Facebook groups related to clinical phenotype:
•

“There are one’s I’m a member of. There's a, there's a fragile X group. There's a
fragile X syndrome group. There's fragile X female carrier symptoms group.
Ummm, there's just a lot like, a lot of groups actually start with fragile X. There's
a fragile X advocacy group” – Participant 3

Participant 2 expressed the importance of finding the FXS resources by stating:
•

“Once you get to know the people that are big in the fragile X world, that feel like
you have a lot more hope, and a lot more of the positive resources” - Participant 2
2.4.3.5 FXS resources parents wished they discovered or had access to sooner

following FXS diagnosis. Participants described the importance of having support
groups, Facebook groups, and information on current research from the time of diagnosis,
along with more information on medical complications that children with FXS may be atrisk for.
•

“Maybe a few of the medical things that show up along the way. So, like with my
son was when he was feeding as a young kid, he threw up a lot… the tonsils and
adenoids are often an issue in fragile X kids… so that would be something if it
was in the research would be very helpful.” – Participant 2
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Additionally, Participant 6 described wanting more balanced and positive
information “Just highlighting the positives. So, like I'm, I'm desperate for someone
telling me something good.” Participant 3 discussed that she would have liked specific
suggestions to join certain Facebook groups or make connections with local FXS groups.
She added:
•

“My husband and I walked out of that appointment and being like, okay, we don't
know what fragile X is and now we're just supposed to look on Facebook groups
online? And like where's the benefit in that? And like what can we do? And what
studies are there? And I just felt like we were lost.” – Participant 3
2.4.3.6 Topics parents identified as lacking resources or information.

Participants expressed a desire for more resources related to educational needs of children
with FXS, girls with FXS transitioning to adulthood, possible medical complications, as
well as managing the behaviors of a child with FXS. Additionally, parents wanted more
ways to connect with parents of older children to gain guidance from them and specific
information on current research progress.
•

“I would love to know more about the best learning programs every year. We're
looking at what's the best kind of math to teach them? What's the best kind of
reading program around to teach them?” – Participant 2

•

“So yes, as much information, as the be put together for school districts,
especially related to writing IEPs” – Participant 2

•

“For people who have fragile X, and who are, you know, functioning enough to
have relationships like, for my daughter. I'm very like hopeful that when she gets
older, like what are the resources for her to have kids?” – Participant 3
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•

“I think just like, where are we in finding a cure for this? Is that like even a
possibility in my kid's lifetime?” – Participant 3

•

“I don't think anything gave me any usable tools and how to deal with a child for
fragile X…doesn't talk about stimming or like, how you deal with a kid who's
stimming or having food issues…” – Participant 3

•

“So yeah, more of maybe an advocacy be helpful if they could have parent
mentors or something to be available to answer specific questions” – Participant 2

•

“Like is there a way you're connecting all the parents so that you know, we can all
like, you know, talk and you know, share ideas and like others have mentioned,
you know, maybe they're further along, you know, their children are older, you
know, maybe they can shed some light and experience” – Participant 5
2.4.3.7 Outdated, inaccurate, or confusing resources. No participant

specifically mentioned any inaccurate or otherwise confusing or outdated resources that
they would not recommend. Participant 3 discussed that she thinks that resources need to
be more “easily searchable” but she specifically said “No I haven’t found anything that’s
fairly outdated or anything.” Participant 5 said “Not really” when asked the same
question. Additionally, Participant 2 said:
•

“Some of them are just long. So if we make abstracts out of some of them, like…I
can't hand a teacher a 30 page PDF and be like, read about fragile X, like,
possibly, maybe a power point, or some sort of slide deck will be more timely for
a teacher.” – Participant 2
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2.4.3.8 Additional information parents wanted to discuss about resources.
Two participants discussed the frequency that they have to educate medical professionals
and teachers about FXS.
•

“I know that there’re obviously are a lot of genetic diseases, but I was just very
um surprised with the lack of knowledge that I found from general practitioners.”
- Participant 3

•

“Every time we need a teacher, like ‘I think I read that in a textbook.’ Like it's just
it's not that common and I don’t expect people to know it, but we're constantly
teaching and learning” – Participant 2
The researcher asked participants at this point about two specific resources to

gauge familiarity: a website called Positive Exposure (positiveexposure.org), and the
book “Children with Fragile X Syndrome: A Parent’s Guide” by Jayne Dixon Weber.
Both were briefly overviewed when describing them to participants. All four participants
expressed interest in these resources but had never come across them. They requested the
primary researcher send the website link and title of the book to them after each meeting.
2.4.3.9 Types of information, readings, and resources parents would provide
a newly diagnosed family. This discussion point elicited many detailed responses from
participants. Participants emphasized the importance of discussing how FXS is a
spectrum, connecting parents to support groups and Facebook groups, and providing
information to national organizations to improve diagnostic experience.
•

“I want to know that it's a spectrum and that there are, you know, parent networks
available” – Participant 3
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•

“The National fragile X website, and then also that State University, that was
doing the research that initially diagnosed my son” – Participant 5

•

“Have written down in the paper that they give you after your appointment like
the local groups or the other, you know, fragile X Foundation websites...” –
Participant 3

•

“I would have liked her to give me more resources, said join this Facebook group
…or we have this is the person in [city] that you should talk to.” – Participant 3

Participant 2 explained the value of educating new parents about fragile X conferences,
and Participant 6 explained how creating a supportive team decreases feelings of
isolation.
•

“My husband and I were able to go to one of the about the national
conferences…that was kind of in a way an eye-opening experience because
literally were put in a room where you saw the severity and saw the positive…we
got to sit in the room and talk with individuals that had been diagnosed, and
maybe their sibling been diagnosed, and I think that was probably one of the best
experiences” – Participant 2

•

“A lot of people from what I've heard have like, really found some amazing
resources and friendships from going to those conferences” – Participant 3

•

“It's yes, you feel alone now, and yes, you're unbelievably sad. And we're going to
give you time to grieve, but here's like a team of people waiting for you to like
help you pick yourself up and get going again” – Participant 6
2.4.3.10 Positivity and Empathy. Throughout these discussions, three of the

participants said they would like more positivity and balanced information at the time of
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diagnosis. Additionally, the manner in which providers discuss FXS with patients is
important; in short: empathy is valued.
•

“Can you just explain and just tell us what this means for his future and
eventually they just told us the best we can hope for was that he could be a bagger
at a grocery store? So, I just I wish they would get more sensitivity training when
delivering the news and what that means for their futures rather than giving such a
doom and gloom type of answer” – Participant 5

•

“There's not a lot of positive stories out there. So, it's kind of It's very daunting to
look ahead” – Participant 6

•

“…once you turn into a teenager, he's going to revolt he's going to be so
aggressive. You should probably start thinking about where his future placement
would be. Yeah. I definitely agree that they need to spend more on the positive in
the potentials instead of the what you're not going to reach…” – Participant 2

One participant highlighted how she appreciated people showing an interest in her child
and stated the people who work at NFXF are good people.
•

“The foundation for fragile X like get back to you right away and they really care,
um and they take it personally” – Participant 3

Participant 2, who had children which were older than the other participants, expressed:
•

“There is a lot to look forward to. They certainly the personalities are so funny.
They're so loving.” – Participant 2
2.4.3.11 FXS Age-Related Information. Participants 2 and 6 shared that

information that was stratified by age group, and developmental levels should be
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more accessible to parents to help families plan and adjust to their child as they
grow.
•

“Some of the Facebook you look at the general fragile X, you have some people
talking about 55-year-old some people talking about 22 year olds and some of
brand new infants” – Participant 2

•

“Let’s do a fragile x like one to three group, a fragile x three to eight group, like,
kind of break it down into like let’s put us into groups.” – Participant 2

Additionally, this kind of information can help assess a child’s progress and help create
new benchmarks.
•

“I feel like if I had a better sense of fragile X kids typically where learned to read
by 5, and then you're like you're making benchmarks based on the actual peer set
at versus, just the kids who happen to have been born around the same time as
him.” – Participant 6

•

“So, if we could kind of chunk it out into developmental stages, whatever that
might look like. I think that might help our planning personalities a little bit to just
think in life stages” – Participant 2

•

“I think that would be really helpful for me to understand because then I know
what to advocate for and what to push back against when people tell me like, hey,
he's not doing well or he is” – Participant 6

2.5 Discussion
This exploratory analysis assessed the satisfaction of parents on the types of
resources they were recommended by various healthcare professionals when their child
was diagnosed with FXS. There have already been studies which demonstrate the
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importance of informational and support resources to families in the time of a new
diagnosis (Goodwin et al., 2015; Lebmann & Sarimski, 2013; Stark & Moller, 2002).
Although some research promotes various resources for families during a diagnostic
experience, and some studies recommend FXS specific resources, there has not been a
study which assessed parental opinions of the existing and recommended resources for
FXS (Finucane et al., 2012; Genetic Alliance, 2010; McConkie-Rosell et al., 2005). The
purpose of this study was to begin to understand the types of resources parents desire at
the time of diagnosis to improve patient-provider relationships and overall diagnostic
experience of families affected by FXS. We predicted that the parents would not be
satisfied with the resources received at the time of diagnosis and that parents are seeking
additional resources independently after a diagnosis to fill a need for more information
and support.
The information revealed in this study supports previous literature discussing how
parents are often unsatisfied with the initial diagnostic appointment at least in part
because they did not receive appropriate provider support or resources (Goodwin et al.,
2015). The information and resources that were most strongly desired at the time of
diagnosis were support resources like local parent groups and Facebook groups, as well
as actionable steps for parents to take with their child moving forward. Another common
sentiment was that more information needs to be provided to participants in an age
appropriate, supportive, and empathetic manner, and more emphasis needs to be placed
on balanced information. These findings align with studies like Lebmann and Sarimski
(2013) which reported that parents expect a supportive approach from their healthcare
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professional during a diagnosis and anticipate gaining informational resources and advice
for next steps in the appointment.
The participants experienced differing initial exposure to resources at the time of
diagnosis. Participant 2 who was provided with the most informational materials and a
referral to a fragile X clinic after diagnosis overall expressed more positivity about the
time of diagnosis than those participants who were directed to search online for resources
or provided with limited guidance on future directions. Participant 2 received information
that other studies have proposed as valuable resources within the FXS community such as
the NFXF and family-oriented articles (McConkie-Roselle et al., 2005). Additionally, the
parents who were told to search online for more information then also expressed in later
discussion that they wished the healthcare professionals would have provided the names
of the best resources on FXS during the diagnosis. This finding supports other literature
which demonstrates that patients generally rely on their healthcare professionals to
provide information and resources which promotes a more positive diagnostic experience
(Genetic Alliance, 2010; Goodwin et al., 2015; Lebmann & Sarimski, 2013). Genetic
counselors are trained in providing information and community and support resources to
patients and utilize these skills in aiding patients through a genetic diagnosis (Genetic
Alliance, 2009).
The participants in this study were newly diagnosed families with little to no prior
knowledge of FXS. Therefore, it is important to remember that the informational needs of
these parents may be different from those where there was a previous family history of
FXS. Families without prior knowledge of FXS may require more detailed information
and basic resources at the time of their child’s diagnosis compared to patients who are
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aware of their risk for years ahead of bearing children. A study which assessed the
communication of genetic risk in adolescent girls with FXS found that many participants
prefer genetic counselors and other healthcare professionals to communicate information
about FXS and genetic risk in an open and honest discussion that is presented in a
positive manner (McConkie-Rosell et al., 2009). Although our participants were not as
prepared for a diagnosis as the girls and women in the McConkie-Rosell et al. (2009)
study, participants in our study agreed that a method of providing positive information
and reassurance to the family is important.
The suggestions from participants of this study support the findings of previous
research that organizations like NFXF, FRAXA, as well as Facebook groups have been
identified as the most beneficial informational and support resources for families
(Finucane et al., 2012; McConkie-Rosell et al., 2005). The mothers who were in this
study also relayed that the national organizations are critical resources at the time of
diagnosis, and two mothers expressed the importance of educating future families about
ongoing research and national conferences. These various resources were often
discovered by participants in their own research. Two of the participants also discussed
how learning about the possible medical complications of FXS or how to adapt therapies
like applied behavior analysis to children with FXS is something they had to search for
on their own. Additionally, emphasis needs to be placed by genetic counselors and other
healthcare professionals that FXS is a spectrum, and some children will be more affected
than others, but there are still resources available to meet your child’s developmental
needs.
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All of the participants recommended Facebook groups as a method of joining the
FXS community and emphasized the groups are a principal component of their resource
and support network. This supports the findings of Lebmann and Sarimski (2013) stating
that 81.3% of parents consider support groups to be important following a FXS diagnosis.
One of the participants in this study specifically identified the various groups she has
found to be beneficial and would want providers to introduce to newly diagnosed
families. Pogue et al. (2018) similarly found that social media has been increasing the
sense of community for patients and families affected by various conditions. One of the
participants explained how social media as a resource can occasionally be overwhelming.
This sentiment demonstrates how genetic counselors and other providers should assess
the needs of the patient when providing resources and may need to provide qualifications
about resources or choose to not disclose certain resources until a later appointment
(Uhlmann et al., 2010).
This study identified areas where parents were unable to locate the resources they
desired. Three of the participants explained that they would like more accessibility to
connect and talk with parents who have older children who had already gone through the
diagnosis; these parents could act as mentors for newly diagnosed parents. One mother
wanted more information on her female daughter transitioning into adulthood and
available resources for females addressing sexuality, relationships, and possible resources
for having biological children. The desires of the parents when viewed holistically show
that parents are looking for age-specific resources for their children. Two participants
specifically mentioned having resources broken up to address the needs of different age
groups would be helpful. It can be noted that there are already resources that exist for
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these topics of interest on the NFXF website and in books such as “Children with Fragile
X Syndrome: A Parent’s Guide” by Jayne Dixon Weber; however, none of the
participants were familiar with the book. It was not explored if participants are not aware
of the resources on the NFXF website about age related guidance, transitioning to
adulthood, education, and methods to connect with other parents, or if they were not
finding these resources satisfactory for their needs. The responses of the participants
support prior research showing that parents require the help of their healthcare
professional to guide them down appropriate avenues of information and to help families
establish strong support networks (Genetic Alliance, 2010; Goodwin et al., 2015;
Lebmann & Sarimski, 2013).
Multiple participants described the time of diagnosis as “shocking”,
“devastating”, or “unbelievably sad” which led to a large discussion in the interview and
focus group about the importance of provider empathy and positivity. Genetic counselors
and healthcare providers should strive to present information about a diagnosis in a
supportive manner to enhance the diagnostic experience (Goodwin et al., 2015). Many
participants in this study expressed they wanted more hope to come across from the
providers, more positive language, balanced negative aspects of the condition with
strengths of people with FXS, and support. One study showed that parents expect
healthcare professionals to deliver advice and information about a diagnosis with an
understanding of the great emotional distress that parents are feeling (Lebmann &
Sarimski, 2013).
The results of this study support previous guidance on the factors that make
informational resources patient appropriate. Davis et al. (2010) at the Center of Disease
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Control (CDC) created a document titled “Simply Put” about creating patient education
materials. It highlights the importance of encouraging and supporting your audience,
providing the audience with action items or next steps to take, and limiting scientific
jargon (Davis et al., 2010). The respondents in this study reflected these principals in
their answers. Parents stressed positivity and empathy from the healthcare provider, the
importance of providing direction after diagnosis, and how parent-friendly materials aid
in comprehension and resource satisfaction. Other resources on developing patient
education materials also stress the importance of focusing on actions the patient can take,
using “plain language”, personalizing educational materials, and the value of providers
organizing their educational materials so they are easily accessible to provide patients
with resources at the time of diagnosis (Guidelines for developing patient education
materials, 2017; Use Health Education material effectively: Tool #12, 2020). This study
supports these previous guidelines on resources; it found that parents feel the provision of
resources needs to be more personalized, comprehensive, and accessible.
2.5.1 Practice Implications
Participants expressed that it is most beneficial for genetic counselors and other
healthcare professionals involved in giving a diagnosis to provide balanced and
supportive information. Parents feel isolation and anxiety during a new diagnosis of their
child and it is the role of the genetic counselor and other providers to appropriately
educate a family about FXS, and also help the family establish a strong resource network.
Genetic counselors are uniquely trained in providing information in an easy-tounderstand manner and often are the healthcare professionals who offer and provide
families with resources. It is important to emphasize that there is a group of providers,
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therapists, and an entire FXS community that is there to support the family. Based on the
results of this study, it seems that parents would like the names of specific resources like
organization names, specific Facebook group names, information about local support
groups, or providers with expertise in FXS, and if possible, a way to connect with a
parent who has already experienced a FXS diagnosis. Multiple parents also expressed the
need-to-know action steps on how to move forward from a diagnosis, so genetic
counselors and providers can remember to give age-appropriate recommendations so
parents can adjust to the diagnosis. Genetic counselors and providers should be prepared
to provide access to resources like the ones listed above, as well as books on FXS or
other regional resources, for future diagnoses of FXS. Additionally, participants did
request information that can be found on web pages such as the NFXF, so it might be
necessary to reassess how accessible these resources are in order to ease the usability of
these sites for parents/guardians.
2.5.2 Limitations and Future Investigation
The findings from this study are limited due to the small sample size (n = 4). The
sample was not representative of all FXS parents as it was primarily composed of
Caucasian females; only one participant identified as part of a minority group, and no
males participated in an interview or focus group discussion. Findings from this
exploratory study can be used in a future study inclusive of a larger, more diverse
population. Study participation could be enhanced by extending time for recruitment and
expanding recruitment avenues possibly through FXS Facebook groups.
Recall bias could have influenced the results of this study as participants were
asked to reflect on a time in their life that was both stressful and shocking. Specific
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questions asked parents to recall resources provided at diagnosis versus ones they
discovered individually which could lead to some participants unintentionally confusing
the resources they were provided at diagnosis with ones they identified online themselves
and vice versa. Additionally, participants self-selected for this study so it is possible that
the participants experienced a more positive or negative diagnosis experience compared
to the typical parent.
Another limitation of this study was the error in the logic of the survey. Future
work should aim to correct this error thereby allowing more participants to initially reach
the end of the survey and prevent complications in contacting participants to begin the
survey again ahead of scheduling them for a focus group or interview.
Future research could also focus on expanding this study to collect more parent
experiences and opinions on exposure to resources at the time of diagnosis. If a larger
sample is obtained, it would be beneficial to stratify participants in focus groups by sex of
the parent or child, age of child at diagnosis, time since diagnosis, prior family history of
FXS, or the type of healthcare provider present at diagnosis. Although the sample size
was small, each of the mothers who participated in the study did not have experience with
FXS prior to their children’s diagnosis, so their reflections begin to highlight the needs of
newly diagnosed families with no prior family history of FXS. The openness of these
families to share their experiences will allow future research to continue to explore parent
experiences with resources and provide more guidance on how genetic counselors and
other healthcare professionals can work to improve the support parents feel during a new
diagnosis. After more information is collected with a broader population, it could be
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possible to utilize parent recommendations to develop a comprehensive guide of patient
friendly resources about FXS to provide parents when their child is diagnosed with FXS.
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CHAPTER 3: CONCLUSIONS
Parents of children recently diagnosed with FXS require more direction and
support from the healthcare professionals involved in providing the diagnosis.
Participants in this study did not feel satisfied with the information and advice they
received from providers and all expressed a need for more positive and balanced
information about FXS. The present study also found that parents are primarily relying on
information and support from national organizations like NFXF and FRAXA, Facebook
groups, and national conferences. These resources are ones that participants would also
recommend providers and genetic counselors educate families about when their child is
diagnosed with FXS. The study identified that parents would like more opportunities to
connect with previously diagnosed families who can serve as friends and mentors during
the adjustment to the new diagnosis. If genetic counselors and providers know of other
parents or local FXS groups who would be willing to speak with the families, referral or
contact information is critical to decrease feelings of isolation. Interestingly, many
participants expressed a desire for information to be presented in an age-appropriate
manner, but some of this can be found on organization pages like NFXF, so it may be
interesting to explore this in further research.
Genetic counselors play a vital role in the diagnosis of children with FXS as they
are uniquely trained to provide complex medical and genetic information in a patientfriendly manner and support the patient by providing appropriate resources. It is
important that genetic counselors and other healthcare professionals remember that the
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time of diagnosis is stressful and parents value balanced information on FXS as well as
further guidance about best resources, local support groups, and age-appropriate next
steps. This research can be used as an initial exploration of how we can continue to
improve future patient experiences, and if expanded to a broader population, can be the
background to developing a comprehensive guide for healthcare professionals on FXS
resources.
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APPENDIX A: NATIONAL FRAGILE X FOUNDATION SOCIAL MEDIA
ADVERTISEMENT
Caption for the below images:
Attention parents of children with Fragile X syndrome: Did you receive the info you
needed when your child was diagnosed? What other resources would have been helpful?
@USCGCP Genetic counseling student, Megan Michalski’s thesis project will help us
better meet the needs of families. You input is critical! Click here to participate!
@NatlFragileX @fragileXsyndrome
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Figure A.1 National Fragile X Foundation social medial photo
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APPENDIX B: GREENWOOD GENETIC CENTER SOCIAL MEDIA
ADVERTISEMENT
Caption for the below images:
Attention parents of children with Fragile X syndrome: Did you receive the info you
needed when your child was diagnosed? What other resources would have been helpful?
@USCGCP Genetic counseling student, Megan Michalski’s thesis project will help us
better meet the needs of families. You input is critical! Click here to participate!
@NatlFragileX @fragileXsyndrome
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Figure B.1 Greenwood Genetic Center social media photo
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APPENDIX C: NATIONAL FRAGILE X FOUNDATION RESEARCH PORTAL
POSTING
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When someone completed the contact form, they saw this message.
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APPENDIX D: GREENWOOD GENETIC CENTER OFFICE ADVERTISEMET

Figure D.1 Recruitment flyer for Greenwood Genetic Center
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APPENDIX E: STUDY QUESTIONNAIRE
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APPENDIX F: FOCUS GROUP SCRIPT AND QUESTIONS
Focus Group Script Introduction
Thank you everyone for participating in today’s focus group! I really
appreciate that you are willing to share your valuable time with us. My name is
Megan, I am a genetic counseling graduate student at the University of South
Carolina. I will be guiding today’s discussion. I would like to remind all of you that
participation in today’s focus group is completely voluntary and you can choose to
not respond to any questions. You may decide to leave this virtual meeting at any
point. Please let me know at any time if there are any technical difficulties on my or
your end so we can try to resolve them to make this discussion flow smoothly.
As was explained on the initial recruitment letter, the purpose of today’s focus
group is to learn more about your opinion about Fragile X resources. Participants in
this group are parents of a child with a full Fragile X mutation. Using these focus
groups, the research team will work to develop reference materials (like a document or
brochure) for healthcare providers to use to suggest resources to parents about Fragile
X Syndrome that are most beneficial.
I really want to hear all of your thoughts and opinions during the discussion
today, so I will be recording the session. Please know that we have strategies to protect
your confidentiality and anonymity. Only researchers will have access to today’s
recording or the transcript from the recording. When we are summarizing results from
this discussion all identifying information will be excluded from your comments or
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quotes to protect your identity. You are not required to share personal identifying
information, including names of yourself or your children.
Due to these measures, I hope you feel comfortable to speak your mind.
Remember you don’t have to answer any question you are not comfortable answering.
I want to ensure everyone today has a chance to speak, so please do not be offended if
I limit any of your comments to allow someone else to speak. I ask that we are
conscious of others and do not talk over someone if they are speaking. I do have
specific questions which you all received ahead of time, but the conversation may take
a natural flow. We do have a random raffle to receive a 25$ Amazon gift card after the
completion of this focus group. Lastly, I ask that you please keep your microphone
muted when you are not speaking if possible, and feel free to utilize the chat function.
Does anyone have any questions before we begin?
Focus Group Questions
1. To start could you please introduce yourself, state how old your child is and
when you got their diagnosis? (You may choose to share your child’s name
if you feel comfortable)
a. What kind of healthcare professional gave you the diagnosis?
b. General pediatrician, Geneticist, Genetic counselor, other
2. Now thinking back to when your child was first diagnosed, what kinds of
resources about Fragile X did that healthcare professional recommend so
that you could learn how to care for your child?
a. (Resources here can include informational books or pamphlets, links
to videos, handouts, reference to patient advocacy groups and
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informational sites like the National Fragile X Foundation, packets
about management and prognosis, or even how to access support
groups or Facebook groups.)
b. Did you look on the web, Facebook, book, brochure, etc.
c. Could you give a specific example of resources that you first
read when your child was diagnosed with Fragile X.
d. your satisfaction or dissatisfaction with them?
e. Topics these references covered
3. When your child was first diagnosed what did you most want to learn about?
a. Did the recommended resources cover this information to the extent that
you wanted?
i. Please expand on this
b. Were you satisfied with the information you learned and how it
was presented from these sources?
4. What other resources about Fragile X did you find on your own?
a. Provide examples
b. Why did you like about these resources, topics covered, etc?
c. What aspects were most useful in these resources?
i. Give me an example of what was useful?
d. What gaps in information did these fill?
e. How did you use the information?
5. Which resources do you wish you knew about earlier than when you found
them?
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a. Provide examples.
b. Explain what made these resources the most beneficial
6. What areas do you wish there were more information on that you cannot find?
a. Is there any information you would like to learn that you cannot find
information on?
b. How could these resources have been made more accessible to you?
7. Are there resources that you have come across or were recommended
that were outdated, overly confusing, inaccurate, or for another reason
ones you did not like?
a. If yes, provide examples please
b. What made you dislike these resources?
c. How could these resources be improved?
8. Have we missed anything about resources that you would like to still discuss?
9. If you were creating resources for parents who have a child with
Fragile X Syndrome, what information do you think is necessary to be
included, where would you direct them for further readings, what do
you want them to know?
a. What resources were most useful when learning about the condition?
b. What resources were most useful when learning how to care for your
child?
Focus Group Conclusion
We have reached the end of this focus group. Thank you again for taking the
time to participate and share your thoughts. As I mentioned the goal of this discussion is
to aid in the creation of a reference for healthcare professionals to know what resources
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to recommend to families affected by Fragile X. You should receive a 1 page summary
of today’s focus group notes within a couple weeks, and as my thesis is completed you
will be updated of the results of this study. Do you have any final questions or thoughts
you would like to share?
The 25$ Amazon gift card can be raffled to this group. If you are selected as
the winner, you will receive an email containing details to the Amazon gift card
tonight! Thank you again for your time this afternoon! Take care.
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APPENDIX G: INTERVIEW SCRIPT AND QUESTIONS
Interview Script Introduction
Thank you for participating in this interview! I really appreciate that you are
willing to share your valuable time for this study. My name is Megan, I am a genetic
counseling graduate student at the University of South Carolina. I would like to
remind you that participation in today’s interview is completely voluntary and you
can choose to not respond to any questions. You may decide to leave this phone call
at any point. Please let me know at any time if there are any technical difficulties on
my or your end so we can try to resolve them to make this interview flow smoothly.
As was explained on the initial recruitment letter, the purpose of today’s
discussion is to learn more about your opinion about Fragile X resources. Participants
in this study are parents of a child with a full Fragile X mutation. Using focus groups
and interviews, the research team will work to develop reference materials (like a
document or brochure) for healthcare providers to use to suggest resources to parents
about Fragile X Syndrome that are most beneficial.
I really want to hear all of your thoughts and opinions during the interview, so I
will be recording the call. Please know that we have strategies to protect your
confidentiality and anonymity. Only I will have access to today’s recording or the
transcript from the recording. When we are summarizing results from this interview all
identifying information will be excluded from your comments or quotes to protect your
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identity. You are not required to share personal identifying information, including
names of yourself or your children.
Due to these measures, I hope you feel comfortable to speak your mind.
Remember you don’t have to answer any question you are not comfortable answering.
I do have specific questions which you received ahead of time, but the interview may
take a natural flow. I also have a random raffle to receive a 25$ Amazon gift card after
the completion of yours and a couple other interviews. Do you have any questions
before we begin?
Focus Group Questions
1. To start could you please introduce yourself, state how old your child is and
when you got their diagnosis? (You may choose to share your child’s name
if you feel comfortable)
a. What kind of healthcare professional gave you the diagnosis?
b. General pediatrician, Geneticist, Genetic counselor, other
2. Now thinking back to when your child was first diagnosed, what kinds of
resources about Fragile X did that healthcare professional recommend so
that you could learn how to care for your child?
a. (Resources here can include informational books or pamphlets, links
to videos, handouts, reference to patient advocacy groups and
informational sites like the National Fragile X Foundation, packets
about management and prognosis, or even how to access support
groups or Facebook groups.)
b. Did you look on the web, Facebook, book, brochure, etc.
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c. Could you give a specific example of resources that you first
read when your child was diagnosed with Fragile X.
d. your satisfaction or dissatisfaction with them?
e. Topics these references covered
3. When your child was first diagnosed what did you most want to learn about?
a. Did the recommended resources cover this information to the extent that
you wanted?
i. Please expand on this
b. Were you satisfied with the information you learned and how it
was presented from these sources?
4. What other resources about Fragile X did you find on your own?
a. Provide examples
b. Why did you like about these resources, topics covered, etc?
c. What aspects were most useful in these resources?
i. Give me an example of what was useful?
d. What gaps in information did these fill?
e. How did you use the information?
5. Which resources do you wish you knew about earlier than when you found
them?
a. Provide examples.
b. Explain what made these resources the most beneficial
6. What areas do you wish there were more information on that you cannot find?
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c. Is there any information you would like to learn that you cannot find
information on?
d. How could these resources have been made more accessible to you?
7. Are there resources that you have come across or were recommended
that were outdated, overly confusing, inaccurate, or for another reason
ones you did not like?
a. If yes, provide examples please
b. What made you dislike these resources?
c. How could these resources be improved?
8. Have we missed anything about resources that you would like to still discuss?
9. If you were creating resources for parents who have a child with
Fragile X Syndrome, what information do you think is necessary to be
included, where would you direct them for further readings, what do
you want them to know?
a. What resources were most useful when learning about the condition?
b. What resources were most useful when learning how to care for your
child?
Focus Group Conclusion
We have reached the end of this interview. Thank you again for taking the time to
participate and share your thoughts. As I mentioned the goal of this discussion is to aid
in the creation of a reference for healthcare professionals to know what resources to
recommend to families affected by Fragile X. You should receive a 1 page summary of
recommendations of resources from other participants, and as my thesis is completed
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you will be updated of the results of this study. Do you have any final questions or
thoughts you would like to share?
The 25$ Amazon gift card can be raffled between those who completed an
interview and focus group. If you are selected as the winner, you will receive an email
containing details to the Amazon gift card in next couple of weeks.
Thank you again for your time this afternoon! Take care.
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APPENDIX H: RESEARCHER COMPILED RESOURCE LIST: PARTICIPANT
RECOMMENDATIONS AND OTHER FRAGILE X RESOURCES
RESOURCES
Thank you everyone for participating in my thesis research highlighting parent
satisfaction related to fragile X syndrome resources provided by healthcare professionals
at the time of diagnosis. Based off of the discussions that we had, I complied a short list
of resources that you as parents seemed to gravitate towards, along with a couple of
resources that I have found in my own research, these are in italics. Maybe some of these
are new to you and you find some new information. Thank you again for your time!
Websites:
- National Fragile X Foundation
o https://fragilex.org/
o https://fragilex.org/living-with-fragile-x/newly-diagnosed/ - information
for a newly diagnosed family
- National Fragile X Foundation – Community Support Networks
o https://fragilex.org/living-with-fragile-x/community-support/
- Positive Exposure
o https://positiveexposure.org/frame/fragile-x/
Facebook Groups:
- Fragile X Female Carrier Symptoms
- Fragile X Syndrome
- NFXF Fragile X Advocacy
- Fragile X
- Girls with Fragile X Syndrome
- Fantastically Fragile X – a Fragile X “brag room” for families
Current Research Studies:
- FRAXA Research Foundation
o https://www.fraxa.org/
- UC Davis MIND Institute
o https://health.ucdavis.edu/mindinstitute/research/fragilex/fragilex-currentresearch.html
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-

ClinicalTrials.gov
o https://clinicaltrials.gov/ct2/results?cond=Fragile+X+Syndrome&term=&c
ntry=&state=&city=&dist=&Search=Search

Books:
- Children with Fragile X Syndrome: A Parent’s Guide – by Jayne Dixon Weber
- X Stories: The Personal Side of Fragile X Syndrome – edited by: Charles W.
Luckmann and Paul S. Piper
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